Charles Winter
Chief Tech/Sci/R&D Officer at JANUX THERAPEUTICS, INC.
Net worth: 3 M $ as of 2024-05-30
Profile
Charles Winter is currently the Chief Technical Officer at Janux Therapeutics, Inc. He previously held positions as the Director-Biologics Development at Gilead Sciences, Inc. from 2011 to 2015, Vice President-Manufacturing & Technology at Eden Biologics, Inc. from 2015 to 2016, Senior Group Leader & Principal Engineer at Genentech, Inc. from 1994 to 2011, Vice President-Chemistry, Manufacturing & Controls at AnaptysBio, Inc. from 2020 to 2021, Vice President-Manufacturing & Controls at Synthorx, Inc. in 2020, and Head-Biologics at Denali Therapeutics, Inc. from 2016 to 2018.
He completed his undergraduate degree at the University of Wisconsin.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
JANUX THERAPEUTICS, INC.
0.10% | 2024-02-14 | 51,458 ( 0.10% ) | 3 M $ | 2024-05-30 |
Charles Winter active positions
| Companies | Position | Start |
|---|---|---|
| JANUX THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2020-12-31 |
Former positions of Charles Winter
| Companies | Position | End |
|---|---|---|
| ANAPTYSBIO, INC. | Corporate Officer/Principal | 2021-02-28 |
| SYNTHORX, INC. | Corporate Officer/Principal | 2020-07-31 |
| DENALI THERAPEUTICS INC. | Corporate Officer/Principal | 2018-05-31 |
| JHL BIOTECH, INC. | Chief Tech/Sci/R&D Officer | 2016-07-31 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 2015-05-31 |
Training of Charles Winter
| University of Wisconsin | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| JANUX THERAPEUTICS, INC. | Health Technology |
| ANAPTYSBIO, INC. | Health Technology |
| DENALI THERAPEUTICS INC. | Health Technology |
| Private companies | 3 |
|---|---|
Eden Biologics, Inc.
 Eden Biologics, Inc. Pharmaceuticals: MajorHealth Technology Eden Biologics, Inc. is engaged in the manufacture and sale of bio-pharmaceuticals products. It offers cell line cloning, antibody cloning, monoclonal antibody, cell line development, master and working cell banks, cell culture process development, purification process development, formulation development, and analytical assays. The company was founded on June 14, 2012 and is headquartered in Zhupei, Taiwan. | Health Technology |
Synthorx, Inc.
 Synthorx, Inc. BiotechnologyHealth Technology Synthorx, Inc. focuses on prolonging and improving lives of cancer and autoimmune disorder patients. Its product pipeline is comprised of THOR-707, IL-2 Synthorin, IL-10 Synthorin, and IL-15 Synthorin. The company was founded by Floyd E. Romesberg and Court R. Turner in 2014 and is headquartered in La Jolla, CA. | Health Technology |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Charles Winter
